More Australian Clinical Labs Ltd news
Australian Clinical Labs LtdASX: ACL

FY24 financial results investor presentation

Aug 28, 2024 at 10:51 PM EDT · Issued by Australian Clinical Labs Ltd

Filed with ASX · Aug 28, 2024 at 10:51 PM EDT

On 6ix: 6ix.com/news/fy24-financial-results-investor-presentation-2

Australian Clinical Labs Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Australian Clinical Labs Ltd on 6ix

In the deck

  • Australian Clinical Labs — FY2024 Earnings Presentation24 slidesAug 29, 2024

Story so far

  • Appendix 4E and FY24 financial statementsAug 29, 2024
  • Media Release - 1H22 Financial ResultsFeb 24, 2022

Earlier from Australian Clinical Labs

  • Appendix 4E and FY24 financial statementsAug 28, 2024
  • FY24 Trading UpdateMay 21, 2024
  • Appendix 4D and 1H24 financial reportsFeb 27, 2024
  • 1H24 investor presentationFeb 27, 2024
  • Notice of withdrawal of offer - Healius LimitedDec 21, 2023

Later from Australian Clinical Labs

  • Notification of buy-back - ACLAug 28, 2024
  • Sale of Crescent Capital shareholdingSep 11, 2024
  • 1H25 financial results investor presentationFeb 25, 2025
  • Appendix 4D and 1H25 financial statementsFeb 25, 2025
  • Response to ASX Aware LetterFeb 27, 2025
All Australian Clinical Labs news releases↗

Follow Australian Clinical Labs into a list and get an email when it puts out news.

Follow Australian Clinical Labs
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer